Stanford University
Showing 11,331-11,340 of 34,464 Results
-
Zherui Han
Postdoctoral Scholar, Electrical Engineering
BioZherui Han received his Ph.D. (2024) in Mechanical Engineering from Purdue University, and B.S. (2019) in Energy and Power Engineering from Huazhong University of Science and Technology in China. He is a recipient of Purdue's Ross Fellowship and Bilsland Dissertation Fellowship. He is now a postdoc at Stanford developing theory for electrothermal transport in 2D systems and devices. His prior works include first-principles modeling of phonon dynamics.
-
Philip C. Hanawalt
Dr. Morris Herzstein Professor in Biology, Emeritus
Current Research and Scholarly InterestsMy current interest includes two principal areas:
1. The molecular basis for diseases in which the pathway of transcription-coupled DNA repair is defective, including Cockyne syndrome (CS) and UV-sensitive syndrome (UVSS). Patients are severely sensitive to sunlight but get no cancers. See Hanawalt & Spivak, 2008, for review.
2. Transcription arrest by guanine-rich DNA sequences and non-canonical secondary structures. Transcription collisions with replication forks. -
Russell Hancock
Lecturer, Public Policy
BioRussell Hancock is president and CEO of Joint Venture Silicon Valley, a group of government and business leaders tackling the region's challenges. He is also the president of the research arm of the organization, the Silicon Valley Institute for Regional Studies.
Educated at Harvard in the field of Government, Dr. Hancock received his Ph.D, in Political Science from Stanford in 1993. He has taught in Stanford's Public Policy Program since 2008, leading the Senior Practicum, and teaching courses about regional politics and decision making. -
Steven Hancock, MD
Professor of Radiation Oncology (Radiation Therapy), Emeritus
Current Research and Scholarly InterestsOutcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
General adult and pediatric radiation therapy.
